UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
January
12, 2010
Date of
Report – (Date of earliest event reported)
CHEM
RX CORPORATION
(Exact
name of registrant as specified in its charter)
Delaware
|
000-51518
|
20-2938469
|
(State
or Other Jurisdiction of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
750
Park Place
Long
Beach, New York 11561
(Address
of principal executive office, including zip code)
(516)
889-8770
(Registrant’s
telephone number)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
|
Item
5.02 – Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
(b) On
January 12, 2010, J. Jay Lobell and David J. Kellman resigned from the board of
directors of Chem Rx Corporation (“Chem Rx”).
(d) On
January 15, 2010, Gary M. Jacobs and Evan Selzer were appointed directors of
Chem Rx.
Gary M. Jacobs is the Chief
Financial Officer of Chem Rx. He became Chief Financial Officer of Chem Rx on
June 12, 2008. From May 2005 to June 2008, Mr. Jacobs was the Chief
Financial Officer and Chief Operating Officer of Gold Force International, Ltd.,
a supplier of gold, silver and pearl jewelry to U.S. retail chains, and Karat
Platinum LLC, a developer of an alternative to platinum. From July 2003 to April
2005, Mr. Jacobs served as President of The Innovative Companies, LLC, a
supplier of natural stone. From October 2001 to February 2003,
Mr. Jacobs served as Executive Vice President of Operations and Corporate
Secretary of The Hain Celestial Group, Inc., a food and personal care products
company. Mr. Jacobs also served as Executive Vice President of Finance,
Chief Financial Officer and Treasurer of The Hain Celestial Group, Inc. from
September 1998 to October 2001. Prior to that, Mr. Jacobs was the Chief
Financial Officer of Graham Field Health Products, Inc., a manufacturing and
distribution company. Mr. Jacobs was employed for 13 years as a member of
the audit staff of Ernst & Young LLP, where he attained the position of
senior manager. He is a certified public accountant and holds a
Bachelor’s of Business Administration in Accounting from Adelphi
University.
Evan Selzer is currently an
Executive Vice President of Chem Rx. Mr. Selzer has been employed by
Chem Rx since March 1989 in various senior management positions including
Director of Purchasing and Vice President. His breadth of experience
includes all operations of Chem Rx’s pharmacy, stock, delivery and purchasing
departments. Mr. Selzer’s current responsibilities include product
purchasing, new technology and general operations.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
CHEM
RX CORPORATION
|
|||
Dated:
January 19, 2010
|
By:
|
/s/
Steven Silva
|
||
Name:
Steven Silva
|
||||
Title:
President and Chief Operating
Officer
|